VivoSim Labs holds annual shareholder meeting, quorum met at 37.26%
VIVS•VivoSim Labs held its annual shareholder meeting on Sept. 30, 2026, with a 37.26% quorum. Shareholders approved an expanded equity plan, a reverse stock split authorization and warrant-related measures, including reducing the exercise price to $0.85 from $9.60.
1. Shareholder approvals
Shareholders approved an amended 2022 equity incentive plan that increased its share pool by 3,165,000 shares and took effect immediately. They authorized a reverse stock split, with the board to set its timing and final ratio within a range of 1-for-5 to 1-for-20, and ratified Rosenberg Rich Baker Berman P.A. as independent auditor for the fiscal year ending March 31, 2027.
2. Warrant measures
Investors approved the issuance of 4,705,883 shares from warrant exercises and a reduction in the warrant exercise price to $0.85 from $9.60.
